BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23935204)

  • 21. Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic.
    Bártolo I; Rocha C; Bartolomeu J; Gama A; Marcelino R; Fonseca M; Mendes A; Epalanga M; Silva PC; Taveira N
    Infect Genet Evol; 2009 Jul; 9(4):672-82. PubMed ID: 18562253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular epidemiology of HIV in Ghana: dominance of CRF02_AG.
    Fischetti L; Opare-Sem O; Candotti D; Sarkodie F; Lee H; Allain JP
    J Med Virol; 2004 Jun; 73(2):158-66. PubMed ID: 15122787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness.
    Bocket L; Cheret A; Deuffic-Burban S; Choisy P; Gerard Y; de la Tribonnière X; Viget N; Ajana F; Goffard A; Barin F; Mouton Y; Yazdanpanah Y
    Antivir Ther; 2005; 10(2):247-54. PubMed ID: 15865219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
    García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
    J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quasispecies analysis of novel HIV-1 recombinants of subtypes A and G reveals no similarity to the mosaic structure of CRF02_AG.
    Powell RL; Konings FA; Nanfack A; Burda S; Urbanski MM; Saa D; Nyambi PN
    J Med Virol; 2007 Sep; 79(9):1270-85. PubMed ID: 17607774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of the viral subtype in the progression of HIV patients].
    Fonseca Gómez C; Pérez Avila J; Pérez Santos L
    Rev Cubana Med Trop; 2007; 59(3):247-53. PubMed ID: 23427464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon.
    Carr JK; Torimiro JN; Wolfe ND; Eitel MN; Kim B; Sanders-Buell E; Jagodzinski LL; Gotte D; Burke DS; Birx DL; McCutchan FE
    Virology; 2001 Jul; 286(1):168-81. PubMed ID: 11448170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AG.
    de Baar MP; Timmermans EC; Bakker M; de Rooij E; van Gemen B; Goudsmit J
    J Clin Microbiol; 2001 May; 39(5):1895-902. PubMed ID: 11326010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
    N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV disease progression and V3 serotypes in Brazil: is B different from B-Br?
    Santoro-Lopes G; Harrison LH; Tavares MD; Xexéo A; Dos Santos AC; Schechter M
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):953-8. PubMed ID: 10890356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3.
    Meloni ST; Kim B; Sankalé JL; Hamel DJ; Tovanabutra S; Mboup S; McCutchan FE; Kanki PJ
    J Virol; 2004 Nov; 78(22):12438-45. PubMed ID: 15507630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau.
    Norrgren H; Marquina S; Leitner T; Aaby P; Melbye M; Poulsen AG; Larsen O; Dias F; Escanilla D; Andersson S; Albert J; Nauclér A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Sep; 16(1):31-8. PubMed ID: 9377122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
    Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
    J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on HIV-1 diversity in Africa: a decade in review.
    Lihana RW; Ssemwanga D; Abimiku A; Ndembi N
    AIDS Rev; 2012; 14(2):83-100. PubMed ID: 22627605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection.
    Esbjörnsson J; Månsson F; Kvist A; Isberg PE; Nowroozalizadeh S; Biague AJ; da Silva ZJ; Jansson M; Fenyö EM; Norrgren H; Medstrand P
    N Engl J Med; 2012 Jul; 367(3):224-32. PubMed ID: 22808957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 Circulating Recombinant Forms (CRFs) and Unique Recombinant Forms (URFs) in Israel, 2010-2018.
    Wagner T; Zuckerman NS; Wax M; Shirazi R; Gozlan Y; Girshengorn S; Marom R; Mendelson E; Turner D; Mor O
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts.
    Touloumi G; Pantazis N; Pillay D; Paraskevis D; Chaix ML; Bucher HC; Kücherer C; Zangerle R; Kran AM; Porter K;
    Clin Infect Dis; 2013 Mar; 56(6):888-97. PubMed ID: 23223594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.